| Literature DB >> 10549453 |
Abstract
The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successful treatment of uterine myomas with menorrhagia in a woman with a renal transplant. There was a significant reduction in menorrhagia, dysmenorrhea, and uterine and myoma size with the use of the LNG-IUS. We believe that this system provides an alternative to conventional hysterectomy and gonadotrophin-releasing hormonal analog medical treatment for uterine myomas, with a possibly inhibitory effect on myoma growth.Entities:
Keywords: Biology; Cancer; Case Studies--women; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Diseases; Endometrial Cancer; Family Planning; Genitalia; Genitalia, Female; Iud; Iud, Hormone Releasing; Levonorgestrel; Menorrhagia; Menstruation Disorders; Neoplasms; Physiology; Renal Effects; Research Methodology; Studies; Urogenital Effects; Urogenital System; Uterine Effects; Uterus; Women
Mesh:
Substances:
Year: 1999 PMID: 10549453 DOI: 10.1016/s0010-7824(99)00061-x
Source DB: PubMed Journal: Contraception ISSN: 0010-7824 Impact factor: 3.375